STOCK TITAN
  1. Home
  2. News
  3. RWLK

ReWalk Robotics to Present at the H.C. WAINWRIGHT 6th Annual Israel Virtual Conference on November 12th, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement will present a fireside chat at the H.C.WAINWRIGHT virtual conference at 01:30 PM EST on Thursday November 12, 2020.

The presentation is available via the following https://journey.ct.events/view/2ace9345-d28f-4f49-8fde-206ffa6847f4 or through the investor section of the company’s website at www.rewalk.com

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.

Contact:
Ori Gon
Chief Financial Officer 
ReWalk Robotics Ltd.
T: +972-4-9590123 
E: investorrelations@rewalk.com

Stock RWLK logo
ReWalk Robotics Ltd.

NASDAQ:RWLK

RWLK Rankings

N/A Ranked by Market Cap
#4143 Ranked by Stock Gains
N/A Ranked by Dividends

RWLK Latest News

Mar 22, 2024
VA STAND Act introduced in the United States Senate
Mar 13, 2024
Lifeward Announces Reverse Share Split
Mar 8, 2024
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
Mar 1, 2024
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
Feb 27, 2024
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

RWLK Stock Data

8.92M
58.82M
1.96%
20.72%
2.27%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
P O Box 161

About RWLK

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the